Disease | polymyositis |
Symptom | C0206062|interstitial lung disease |
Sentences | 11 |
PubMedID- 20367973 | Predictive factors and unfavourable prognostic factors of interstitial lung disease in patients with polymyositis or dermatomyositis: a retrospective study. |
PubMedID- 23158422 | Objective: to explore the possible diagnostic values of serum surfactant protein-a (sp-a) and surfactant protein-d (sp-d) for interstitial lung diseases (ild) in patients with polymyositis or dermatomyositis (pm/dm). |
PubMedID- 24142786 | interstitial lung disease in patients with polymyositis and dermatomyositis--report of three cases. |
PubMedID- 25297551 | interstitial lung disease (ild) in patients with polymyositis (pm) and dermatomyositis (dm) is often resistant to treatment and life threatening, being recognized as one of the severest complication in these autoimmune disorders. |
PubMedID- 23423441 | This diagnosis should always come to mind in patients that present with signs of myositis, dermatomyositis, or polymyositis associated with interstitial lung disease. |
PubMedID- 22325787 | Clinical factors to predict a poor prognosis and refractory disease in patients with polymyositis and dermatomyositis associated with interstitial lung disease. |
PubMedID- 21950266 | Kl-6: a serological biomarker for interstitial lung disease in patients with polymyositis and dermatomyositis. |
PubMedID- 25827843 | Predictive value of serum markers for the development of interstitial lung disease in patients with polymyositis and dermatomyositis: a comparative and prospective study. |
PubMedID- 24800252 | Objective: hyperferritinemia is frequently accompanied by rapidly progressive (rp) interstitial lung disease (ild) with polymyositis (pm)/dermatomyositis (dm). |
PubMedID- 26101728 | Incidence and impact of interstitial lung disease and malignancy in patients with polymyositis, dermatomyositis, and clinically amyopathic dermatomyositis: a retrospective cohort study. |
PubMedID- 21285059 | polymyositis associated with severe interstitial lung disease: remission after three doses of iv immunoglobulin. |
Page: 1